Cargando…

Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease

The purpose of the study was to assess whether the occurrence of restenosis is associated with CD45+ platelet count and neutrophil to lymphocyte ratio in patients with type 2 diabetes mellitus (DM) after drug-eluting stent (DES) implantation for stable coronary artery disease (CAD). The study compri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabbasov, Zufar, Kozlov, Sergey, Melnikov, Ivan, Byazrova, Svetlana, Saburova, Olga, Prokofieva, Lyudmila, Caprnda, Martin, Curilla, Eduard, Gaspar, Ludovit, Rodrigo, Luis, Kruzliak, Peter, Smirnov, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714775/ https://www.ncbi.nlm.nih.gov/pubmed/29716394 http://dx.doi.org/10.1177/1076029618771752

Ejemplares similares

Platelet Adhesion Mediated by von Willebrand Factor at High Shear Rates Is Associated with Premature Coronary Artery Disease
por: Okhota, Sergey, et al.
Publicado: (2023)

CRP Is Transported by Monocytes and Monocyte-Derived Exosomes in the Blood of Patients with Coronary Artery Disease
por: Melnikov, Ivan, et al.
Publicado: (2020)

Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives
por: Melnikov, Ivan, et al.
Publicado: (2023)

The monomeric C-reactive protein level is associated with the increase in carotid plaque number in patients with subclinical carotid atherosclerosis
por: Melnikov, Ivan, et al.
Publicado: (2022)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Kinetics of platelet adhesion to a fibrinogen‐coated surface in whole blood under flow conditions
por: Gabbasov, Zufar A., et al.
Publicado: (2021)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology
por: Okhota, Sergey, et al.
Publicado: (2020)

The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents
por: Nikaeen, Fariborz, et al.
Publicado: (2011)

Von Willebrand factor in diagnostics and treatment of cardiovascular disease: Recent advances and prospects
por: Kozlov, Sergey, et al.
Publicado: (2022)

Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2013)

Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation
por: Liang, Hengyi, et al.
Publicado: (2020)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Zhu, Yong, et al.
Publicado: (2021)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Coronary restenosis
Publicado: (1993)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Value of M2BP in predicting in‐stent restenosis in patients after coronary drug‐eluting stent implantation
por: Yang, Le, et al.
Publicado: (2022)

Postprandial changes of lipoprotein profile: effect of abdominal obesity
por: Sabaka, Peter, et al.
Publicado: (2013)

One-year outcomes following drug-eluting balloon use for coronary ostial restenosis
por: Lee, Wei-Chieh, et al.
Publicado: (2015)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
por: Xi, Hongfei, et al.
Publicado: (2023)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation
por: Lee, Hye Won, et al.
Publicado: (2013)

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
por: Tornyos, Adrienn, et al.
Publicado: (2017)

The impact of acute coronary syndrome on late drug-eluting stents restenosis: Insights from optical coherence tomography
por: Wu, Sijing, et al.
Publicado: (2017)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Adjuvant Cardioprotection in Cardiac Surgery: Update
por: Wagner, Robert, et al.
Publicado: (2014)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Effect of Pioglitazone on In-Stent Restenosis after Coronary Drug-Eluting Stent Implantation: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ming-duo, et al.
Publicado: (2014)

Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting
por: Liu, Wenquan, et al.
Publicado: (2023)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cleu6ug8k9sruevl0cle097l3d